Navigation Links
MPM Capital Leads Investment in Proteon Therapeutics
Date:3/5/2009

Dr. Steven St. Peter Named to Proteon Board of Directors

KANSAS CITY, Mo., March 5 /PRNewswire/ -- MPM Capital, one of the world's largest life sciences-dedicated venture capital investors, announced today that it is the lead investor in a $38 million Series B equity financing of Proteon Therapeutics. In addition, Dr. Steven St. Peter, Managing Director of MPM Capital, has been named to the Proteon Therapeutics Board of Directors.

Proteon recently initiated a Phase 1/2 clinical trial of its lead product, PRT-201. PRT-201 is a recombinant human elastase that is being studied for its ability to improve arteriovenous fistula (AVF) surgery outcomes in patients requiring chronic hemodialysis.

"MPM continues to be very impressed with Proteon and the progress that the company has made," said Dr. Steven St. Peter. "In addition, this marks the first investment by MPM in a company with a substantial Kansas City presence. We have long followed the positive developments in the Kansas City area life sciences sector, and this investment affirms our view that attractive opportunities originate there."

Over the last several years, Dr. Steven St. Peter has worked informally with the Kansas City Area Life Sciences Institute in an advisory capacity. In addition, he currently serves as a member of the Kansas Bioscience Authority's Heartland BioVentures Advisory Board. Originally from Wichita, Dr. St. Peter has a B.A. in Chemistry from the University of Kansas. He completed his Doctor of Medicine at Washington University in St. Louis and his residency and fellowship at the Hospital of the University of Pennsylvania.

"Proteon is very pleased to have attracted the interest of MPM Capital, one of the world's premier healthcare venture capital firms," said F. Nicholas Franano, M.D., Chief Scientific Officer and founder of Proteon Therapeutics. "MPM's understanding of
'/>"/>

SOURCE MPM Capital
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
2. AtriCure to Present at Roth Capital Partners 2007 New York Conference
3. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
4. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
5. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
6. iCAD to Present at Americas Growth Capital 4th Annual Emerging Growth Conference
7. Pharsight Files Application for Nasdaq Capital Market Listing
8. Advanced Life Sciences Joins NASDAQ Capital Market
9. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
10. Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds
11. Caxton-Iseman Capital Acquires Conney Safety Products, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... Bahama (PRWEB) May 05, 2015 Okyanos, ... Orthopedic Lifestyle Report today. The study was conducted to ... such as osteoarthritis and sports-related injuries have ... and stiffness was the most prevalent symptom reported at ... such as walking, standing and bending over. Over half ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 With ... Josie's Organics, one of the country's leading organic ... minds of moms across the country. What to ... family recipe box or spend hours browsing Pinterest ... on http://www.josiesorganics.com/recipes . , The new ...
(Date:5/5/2015)... 2015 In the upbeat Moms Helping Moms ... moms to support each other. Parenting is a tough ... makes it so much easier. Mothers talk about how ... less alone and help them realize there’s no perfect parent; ... who are clearly dear friends share that it's just that, ...
(Date:5/5/2015)... May is National Osteoporosis Month, and also marks ... Bone Health . Founded by Charles T. Price, MD, the ... and physicians about the latest advances in bone care, and ... to a study recently published by the Journal of Bone ... osteoporosis and low bone mass. This breaks down to a ...
(Date:5/5/2015)... St.Louis MO (PRWEB) May 05, 2015 ... innovative bar flavors in 2014, Walgreens introduces the Cookies ... By focusing on innovation, Extend Nutrition has continually raised ... achieved a great taste, combined with an unprecedented nutritional ... Building on this success, Extend Nutrition will launch additional ...
Breaking Medicine News(10 mins):Health News:Okyanos Study Finds Orthopedic Patients Plagued with Pain 2Health News:Okyanos Study Finds Orthopedic Patients Plagued with Pain 3Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 2Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 3Health News:Josie's Organics Kicks Off Mother's Day, Graduation and Grilling Season with New, Easy-to-Follow, Convenient Recipes 4Health News:Just In Time For Mother’s Day, Healthy Birth Day Releases Video Titled “Moms Helping Moms” Encouraging Mothers To Band Together 2Health News:The Institute for Better Bone Health Observes National Osteoporosis Month, Celebrates Three Years of Promoting Healthy Bones 2Health News:The Institute for Better Bone Health Observes National Osteoporosis Month, Celebrates Three Years of Promoting Healthy Bones 3Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 3Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 4
... in ovarian cancer has provided the most comprehensive and integrated ... Ovarian serous adenocarcinoma tumors from 500 patients were examined by ... reported in the June 30, 2011, issue of Nature ... of ovarian cancer, accounting for about 85 percent of all ...
... (HealthDay News) -- Obesity is a major risk factor ... women, a new study finds. It included more than ... smoked and were followed for 28 years. During that time, ... disease and 487 (27 percent) from cancer. Researchers found ...
... recent study accepted for publication in The Endocrine Society,s ... early, prolonged treatment with the diabetes drug metformin may prevent ... adolescence. PCOS affects 7 to 10 percent of ... of infertility, affecting an estimated 5 to 6 million women ...
... Reporter , TUESDAY, June 28 (HealthDay News) -- A vaccine ... some promise, while another designed to alter insulin production fails, ... results of both studies were slated to be presented Tuesday ... Type 1 diabetes often appears early in life and ...
... are teaming up to offer one of the nation,s ... trucks. Led by the University of Maryland and ... program will target the so-called short-haul "drayage" fleet that ... The effort seeks to double the impact ...
... TUESDAY, June 28 (HealthDay News) -- Mammography screening reduces breast ... according to a new, large-scale Swedish trial. In a ... longest ever -- the researchers found that the benefits of ... In fact, most of the benefits occur more than 10 ...
Cached Medicine News:Health News:The Cancer Genome Atlas completes detailed ovarian cancer analysis 2Health News:The Cancer Genome Atlas completes detailed ovarian cancer analysis 3Health News:Obesity a Major Cause of Early Death in Women: Study 2Health News:Diabetes drug may prevent or delay development of polycystic ovary syndrome 2Health News:Trials of Type 1 Diabetes Vaccines Bring Mixed Results 2Health News:Trials of Type 1 Diabetes Vaccines Bring Mixed Results 3Health News:Mid-Atlantic states' unique plan to replace region's dirtiest trucks 2Health News:Mid-Atlantic states' unique plan to replace region's dirtiest trucks 3Health News:Longest Trial Ever Confirms Mammograms' Benefits 2Health News:Longest Trial Ever Confirms Mammograms' Benefits 3
(Date:5/5/2015)... , May 5, 2015  Boehringer Ingelheim Pharmaceuticals, ... company,s respiratory portfolio will be presented at the ... place May 15-20 in Denver ... obstructive pulmonary disease (COPD) and asthma, and on ... COPD. Of the 29 accepted abstracts, 19 are ...
(Date:5/5/2015)... 5, 2015 Merrimack Pharmaceuticals, Inc. (Nasdaq: ... randomized, double-blinded, placebo-controlled Phase 2 clinical trial of ... in combination with nab-paclitaxel and gemcitabine, versus nab-paclitaxel ... pancreatic cancer who have high serum levels of ... fourth leading cause of cancer death in ...
(Date:5/5/2015)... 5, 2015  InfuSystem Holdings, Inc. (NYSE MKT: INFU), ... services for the U.S. healthcare industry, today announced that ... May 12, 2015 after the market closes. ... investors on Tuesday, May 12, 2015 at 4:30 p.m. ... To participate in this call, please dial in toll-free ...
Breaking Medicine Technology:Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference 2Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference 3Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference 4Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference 5Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference 6Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference 7Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference 8Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference 9Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference 10Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference 11Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference 12Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference 13Boehringer Ingelheim to Present 29 Abstracts at the Annual American Thoracic Society International Conference 14Merrimack Pharmaceuticals Announces Initiation of a Phase 2 Front-line Clinical Trial of MM-141 in Biomarker-Selected Patients with Metastatic Pancreatic Cancer 2Merrimack Pharmaceuticals Announces Initiation of a Phase 2 Front-line Clinical Trial of MM-141 in Biomarker-Selected Patients with Metastatic Pancreatic Cancer 3Merrimack Pharmaceuticals Announces Initiation of a Phase 2 Front-line Clinical Trial of MM-141 in Biomarker-Selected Patients with Metastatic Pancreatic Cancer 4
... VIEW, Calif., April 11, 2011 VIVUS, Inc. (NASDAQ: ... 56-week CONQUER study were published in ... safety of investigational drug QNEXA in 2,487 patients across 93 ... provided an in-depth look at weight loss and improvements in ...
... Life-saving Colorado start-up UrgentRx today announced the ... credit card-sized packets are available now at Dahl,s pharmacies, ... first made its powdered medications available across Colorado in ... of UrgentRx Aspirin to Go , UrgentRx ...
Cached Medicine Technology:QNEXA® Phase 3 Data in The Lancet Show Significant Weight Loss and Broad Improvements in Co-Morbidities 2QNEXA® Phase 3 Data in The Lancet Show Significant Weight Loss and Broad Improvements in Co-Morbidities 3QNEXA® Phase 3 Data in The Lancet Show Significant Weight Loss and Broad Improvements in Co-Morbidities 4UrgentRx® Launches Innovative Line of Portable Life-Saving Medications Across Iowa 2UrgentRx® Launches Innovative Line of Portable Life-Saving Medications Across Iowa 3
White Standard Girdle...
Black Spandex Above the Knee Compression Girdles with Contact Closure with Zipper...
Short Girdle, Mid-thigh, Front Closure...
Male Body Shaper, Front Closure...
Medicine Products: